MSDS   | : | Antipyrine, 4-isopropyl-
| CAS   | : | 479-92-5 | SYNONYMS   | : | * 2,3-Dimethyl-4-isopropyl-1-phenyl-3H-pyrazolin-5-one
* Isopropylantipyrin
* Isopropylantipyrine
* 4-Isopropylantipyrine
* 4-Isopropyl-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one
* Isopropylphenazone
* Isopropyrine
* Larodon
* 1-Phenyl-2,3-dimethyl-4-isopropyl-3-pyrazolin-5-one
* 1-Phenyl-2,3-dimethyl-4-isopropylpyrazol-5-one
* Propyphenazone
* 3-Pyrazolin-5-one, 2,3-dimethyl-4-isopropyl-1-phenyl-
* 3-Pyrazolin-5-one, 4-isopropyl-2,3-dimethyl-1-phenyl-
* 3H-Pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-4-(1-methylethyl)-2-phenyl-
|
| |
|
|
*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : CD2800000
CHEMICAL NAME : Antipyrine, 4-isopropyl-
CAS REGISTRY NUMBER : 479-92-5
BEILSTEIN REFERENCE NO. : 0204533
REFERENCE : 5-24-01-00408 (Beilstein Handbook Reference)
LAST UPDATED : 199701
DATA ITEMS CITED : 7
MOLECULAR FORMULA : C14-H18-N2-O
MOLECULAR WEIGHT : 230.34
WISWESSER LINE NOTATION : T5NNVJ A1 BR& DY1&1 E1
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* 2,3-Dimethyl-4-isopropyl-1-phenyl-3H-pyrazolin-5-one
* Isopropylantipyrin
* Isopropylantipyrine
* 4-Isopropylantipyrine
* 4-Isopropyl-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one
* Isopropylphenazone
* Isopropyrine
* Larodon
* 1-Phenyl-2,3-dimethyl-4-isopropyl-3-pyrazolin-5-one
* 1-Phenyl-2,3-dimethyl-4-isopropylpyrazol-5-one
* Propyphenazone
* 3-Pyrazolin-5-one, 2,3-dimethyl-4-isopropyl-1-phenyl-
* 3-Pyrazolin-5-one, 4-isopropyl-2,3-dimethyl-1-phenyl-
* 3H-Pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-4-(1-methylethyl)-2-phenyl-
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 860 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
YKKZAJ Yakugaku Zasshi. Journal of Pharmacy. (Nippon Yakugakkai, 2-12-15
Shibuya, Shibuya-ku, Tokyo 150, Japan) No.1- 1881-
Volume(issue)/page/year: 97,601,1977
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 960 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 9,401,1959
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 295 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4-
1898- Volume(issue)/page/year: 122,434,1959
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - cat
DOSE/DURATION : 150 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
Behavioral - excitement
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &
Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Volume(issue)/page/year: 61,205,1937
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 500 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
Behavioral - excitement
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &
Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Volume(issue)/page/year: 61,205,1937
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - guinea pig
DOSE/DURATION : 1050 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
SMWOAS Schweizerische Medizinische Wochenschrift. (Schwabe & Co.,
Steintorst 13, 4010 Basel, Switzerland) V.50- 1920-
Volume(issue)/page/year: 84,351,1954
*** STATUS IN U.S. ***
EPA TSCA Section 8(b) CHEMICAL INVENTORY
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
Antineoplaston A5
| 142191-84-2 |
Antineoplaston AS2-1
| 104624-98-8 |
Antineoplaston AS2-5
| 104771-87-1 |
Antibiotic SF 1306A
| 52934-70-0 |
Antiogoside
| 3981-17-7 |
Antioside
| 3981-16-6 |
Antioxidant G-15
| 3981-16-6 |
Antioxidant G-16
| 61373-87-3 |
Antioxidant KSM
| 52622-55-6 |
Antioxidant TSP
| 12789-66-1 |
Antiphlei factor-ISUBSTANCE DEFINITION :Isolated from Streptomyces aureusREFERENCE :85GDA2 "CRC Handbook of Antibiotic Compounds," Vols.1- , Berdy, J., BocaRaton, FL, CRC Press, 1980- Volume(issue)/page/year: 1,407,1980
| 12789-66-1 |
Antipyrine
| 60-80-0 |
Antipyrine, 4-(beta-acetylstyryl)-
| 24428-81-7 |
Antipyrine, 4-allyl-
| 24428-81-7 |
Antibiotic SF-1670-A
| 60440-43-9 |
Antipyrine, 4-amino-
| 83-07-8 |
Antipyrine, 4-(2-(p-aminobenzoyl)ethyl)-
| 24428-98-6 |
Antipyrine, 4-amino-, and sodium nitrite
| 24428-98-6 |
Antipyrine, 4-(2-(p-anisoyl)vinyl)-
| 24428-77-1 |
Antipyrine, 4,4'-azodi-
| 102585-65-9 |
Antipyrine, 4-(2-benzoylpropenyl)-
| 24428-80-6 |
Antipyrine, 4-(2-benzoylvinyl)-
| 15183-03-6 |
Antipyrine, 4-butyl-
| 101496-03-1 |
Antipyrine, 4-sec-butyl-
| 96974-48-0 |
Antipyrine, compd. with chloral hydrate (12)
| 480-30-8 |
Antibiotic SF 2107 A(sub 1)
| 81030-78-6 |
Antipyrine, 4-(2-(p-chlorobenzoyl)vinyl)-
| 24429-12-7 |
Antipyrine, 4-((p-chlorophenacylidene)amino)-
| 24377-61-5 |
Antipyrine, 4-(2-(diethylamino)ethyl)-
| 24377-61-5 |
Antipyrine,4-((3,4-dimethoxy-2-(1-pyrrolidinylcarbonyl)benzylidene)amino)-
| 66913-52-8 |
Antipyrine, 4-(dimethylamino)-
| 58-15-1 |
Antipyrine, 4-(dimethylamino)- mixed with sodiumnitrite (1:1)
| 58-15-1 |
Antipyrine, 4-(dimethylamino)-, sodium salt
| 6062-19-7 |
Antipyrine, 4-(2,6-dimethylpiperidinothiocarbamoyl)-
| 73791-34-1 |
Antipyrine, 4-ethyl-
| 73791-34-1 |
Antipyrine, 4-(ethylamino)-
| 15166-10-6 |
Antibiotic SF 1306B
| 52934-72-2 |
Antipyrine, 4-(2-(p-hydroxybenzoyl)propenyl)-,hydrate
| 26405-20-9 |
Antipyrine, 4-isobutyl-
| 26405-20-9 |
Antipyrine, 4-isopentyl-
| 26405-20-9 |
Antipyrine, 4-isopropyl-
| 479-92-5 |
Antipyrine, 4-(isopropylamino)-
| 3615-24-5 |
Antipyrine, 4-((m-methoxybenzylidene)amino)-
| 70318-54-6 |
Antipyrine, 4-((p-methoxybenzylidene)amino)-
| 32061-14-6 |
Antipyrine, 4-((p-methoxyphenacylidene)amino)-
| 24428-97-5 |
Antipyrine, 4-(methylamino)-
| 519-98-2 |
Antipyrine, 4-((p-methylphenacylidene)amino)-
| 24428-96-4 |
Antibiotic SF 1771B
| 63798-93-6 |
Antipyrine,4-(4-(3-methyl-2-phenylmorpholino)methyl)-, gentisate
| 63798-93-6 |
Antipyrine,4-(4-(3-methyl-2-phenylmorpholino)methyl)-,hydrochloride
| 50321-35-2 |
|
|